The US Federal Reserve injected $13.5 billion into the banking system through overnight repurchase agreements. This marks the second-largest single-day liquidity operation since the COVID-19 crisis.

The Federal Reserve will end Quantitative Tightening on December 1st, halting SOMA portfolio reductions after a $2.4 trillion shrinkage since June 2022. Money market conditions signal reserve levels ...

The process for the Special Intensive Revision (SIR) of electoral rolls have already started in West Bengal and people are submitting their SIR forms or Enumeration Form. If you have submitted the ...

Long QT syndrome is a leading cause of sudden death in young persons, with a prevalence exceeding 1 in 2000. It is characterized by prolongation of the QT interval, aberrant T-wave morphologic ...

BIRMINGHAM, Ala., Nov. 10, 2025 /PRNewswire/ -- MDI, a leading Insurtech company specializing in cloud-based core system solutions for life, health, annuity insurance, and risk management sectors, has ...

The administration of President Donald Trump has ordered the creation of "quick reaction forces" in each state, composed of about 500 National Guard members per state, according to reports from The ...

NEW YORK, Oct 14 (Reuters) - The U.S. labor market remained mired in its low-hiring, low-firing doldrums through September, though the economy overall "may be on a somewhat firmer trajectory than ...

GUI design can be a tedious job, requiring the use of specialist design tools and finding a suitable library that fits your use case. If you’re looking for a lightweight solution, though, you might ...

Community driven content discussing all aspects of software development from DevOps to design patterns. Ready to develop your first AWS Lambda function in Python? It really couldn’t be easier. The AWS ...

Though nearly dissuaded by the listing photos, a family made a Tuscan-style house into an indoor-outdoor destination inspired by their travels. The heart of the home is a reconfigured great room with ...

In an Aug. 7 earnings call, Eli Lilly CEO David Ricks told investors that the company plans to submit the drug, orforglipron, to the FDA for approval by the end of the year. Dan Skovronsky, chief ...